Literature DB >> 3119785

Effects of radiation on ovarian function in long-term survivors of childhood acute lymphoblastic leukemia: a report from the Childrens Cancer Study Group.

M R Hamre1, L L Robison, M E Nesbit, H N Sather, A T Meadows, J A Ortega, G J D'Angio, G D Hammond.   

Abstract

The Childrens Cancer Study Group has assessed serum follicle-stimulating hormone (FSH), luteinizing hormone (LH), and pubertal development in 97 long-term female survivors of childhood acute lymphoblastic leukemia (ALL). All patients received identical induction and maintenance therapy with either 18 or 24 Gy of radiation therapy (RT) to one of the following fields: cranial, craniospinal, or craniospinal plus 12 Gy abdominal RT including the ovaries. Thirty-six percent (35 patients) were found to have above normal levels of FSH and/or LH. The percentages of elevated values for RT fields were 93% for craniospinal plus abdominal RT, 49% for craniospinal RT, and 9% for cranial RT (P less than .001). A dose-response relationship was observed between 18 Gy and 24 Gy in females receiving only craniospinal RT (P = .01). Craniospinal plus abdominal RT and abnormal FSH/LH levels were significantly associated with lack of pubertal development and delayed onset of menses. Duration of maintenance chemotherapy was not associated with abnormal gonadotropin levels or the development of secondary sexual characteristics. Additional follow-up of this cohort is needed to establish the ultimate pubertal development and fertility of these patients.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3119785     DOI: 10.1200/JCO.1987.5.11.1759

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  8 in total

Review 1.  Endocrine sequelae of cancer therapy in childhood.

Authors:  F B Diamond; B B Bercu
Journal:  J Endocrinol Invest       Date:  2001-10       Impact factor: 4.256

Review 2.  Chronic disease in the Childhood Cancer Survivor Study cohort: a review of published findings.

Authors:  Lisa Diller; Eric J Chow; James G Gurney; Melissa M Hudson; Nina S Kadin-Lottick; Toana I Kawashima; Wendy M Leisenring; Lillian R Meacham; Ann C Mertens; Daniel A Mulrooney; Kevin C Oeffinger; Roger J Packer; Leslie L Robison; Charles A Sklar
Journal:  J Clin Oncol       Date:  2009-04-13       Impact factor: 44.544

Review 3.  Endocrine consequences of treatment of malignant disease.

Authors:  S M Shalet
Journal:  Arch Dis Child       Date:  1989-11       Impact factor: 3.791

4.  Conducting cancer control and survivorship research via cooperative groups: a report from the American Society of Preventive Oncology.

Authors:  Oxana Palesh; Wendy Demark-Wahnefried; Karen Mustian; Lori Minasian; Julia Rowland; Lisa Sprod; Michelle Janelsins; Luke Peppone; Jeff Sloan; Karen Basen Engquist; Lee Jones; Diana Buist; Electra D Paskett
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-04-18       Impact factor: 4.254

5.  Pubertal development and primary ovarian insufficiency in female survivors of embryonal brain tumors following risk-adapted craniospinal irradiation and adjuvant chemotherapy.

Authors:  Mariko DeWire; Daniel M Green; Charles A Sklar; Thomas E Merchant; Dana Wallace; Tong Lin; Tamara Vern-Gross; Larry E Kun; Matthew J Krasin; James M Boyett; Karen D Wright; Cynthia Wetmore; Alberto Broniscer; Amar Gajjar
Journal:  Pediatr Blood Cancer       Date:  2014-10-18       Impact factor: 3.167

6.  Fertility of female survivors of childhood cancer: a report from the childhood cancer survivor study.

Authors:  Daniel M Green; Toana Kawashima; Marilyn Stovall; Wendy Leisenring; Charles A Sklar; Ann C Mertens; Sarah S Donaldson; Julianne Byrne; Leslie L Robison
Journal:  J Clin Oncol       Date:  2009-04-13       Impact factor: 44.544

7.  Reproductive late effects in female survivors of childhood cancer.

Authors:  Shivany Gnaneswaran; Rebecca Deans; Richard J Cohn
Journal:  Obstet Gynecol Int       Date:  2012-05-06

8.  Involved Site Radiotherapy Extends Time to Premature Menopause in Infra-Diaphragmatic Female Hodgkin Lymphoma Patients - An Analysis of GHSG HD14- and HD17-Patients.

Authors:  Johannes Rosenbrock; Andrés Vásquez-Torres; Horst Mueller; Karolin Behringer; Matthias Zerth; Eren Celik; Jiaqi Fan; Maike Trommer; Philipp Linde; Michael Fuchs; Peter Borchmann; Andreas Engert; Simone Marnitz; Christian Baues
Journal:  Front Oncol       Date:  2021-05-25       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.